Cellular resilience in neurotoxicity: The case of Parkinson's disease

被引：0
|
作者：
Smirnova, L. [1 ]
Harris, G. [1 ]
Zhao, L. [1 ]
Maertens, A. [1 ]
Hartung, T. [1 ]
机构：
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Alternat Anim Testing, Baltimore, MD 21218 USA
来源：
TOXICOLOGY LETTERS | 2016年 / 258卷
关键词：
D O I：
10.1016/j.toxlet.2016.06.1568
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P08-025
引用
收藏
页码：S147 / S147
页数：1
相关论文
共 50 条
  • [31] Dieldrin-induced neurotoxicity: Relevance to Parkinson's disease pathogenesis
    Kanthasamy, AG
    Kitazawa, M
    Kanthasamy, A
    Anantharam, V
    NEUROTOXICOLOGY, 2005, 26 (04) : 701 - 719
  • [32] Synphilin Suppresses α-Synuclein Neurotoxicity in a Parkinson's Disease Drosophila Model
    Hernandez-Vargas, Rene
    Fonseca-Ornelas, Luis
    Lopez-Gonzalez, Ignacio
    Riesgo-Escovar, Juan
    Zurita, Mario
    Reynaud, Enrique
    GENESIS, 2011, 49 (05) : 392 - 402
  • [33] Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson's disease
    Shin, Eun-Joo
    Jeong, Ji Hoon
    Hwang, Yeonggwang
    Sharma, Naveen
    Dang, Duy-Khanh
    Nguyen, Bao-Trong
    Nah, Seung-Yeol
    Jang, Choon-Gon
    Bing, Guoying
    Nabeshima, Toshitaka
    Kim, Hyoung-Chun
    ARCHIVES OF PHARMACAL RESEARCH, 2021, 44 (07) : 668 - 688
  • [34] Enhancement of dopaminergic neurotoxicity by the mercapturate of dopamine: Relevance to Parkinson's disease
    Zhang, J
    Kravtsov, V
    Amarnath, V
    Picklo, MJ
    Graham, DG
    Montine, TJ
    JOURNAL OF NEUROCHEMISTRY, 2000, 74 (03) : 970 - 978
  • [35] Defective Fas expression exacerbates neurotoxicity in a model of Parkinson's disease
    Landau, AM
    Luk, KC
    Jones, ML
    Siegrist-Johnstone, R
    Young, YK
    Kouassi, E
    Rymar, VV
    Dagher, A
    Sadikot, AF
    Desbarats, J
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (05): : 575 - 581
  • [36] Chronic Systemic Inflammation Exacerbates Neurotoxicity in a Parkinson's Disease Model
    Ugalde-Muniz, Perla
    Fetter-Pruneda, Ingrid A.
    Navarro, Luz
    Garcia, Esperanza
    Chavarria, Anahi
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
  • [37] Neurotoxicity of DOPAL, the MAO metabolite of dopamine: Implications for Parkinson's disease
    Burke, WJ
    Li, SW
    Zahm, S
    Kristal, BS
    NEUROLOGY, 1999, 52 (06) : A345 - A345
  • [38] Network Attack Tolerance: A Resilience Proxy for Parkinson's Disease?
    Asendorf, A.
    Temizyurek, A.
    Banwinkler, M.
    Dzialas, V.
    van Eimeren, T.
    Hoenig, M.
    MOVEMENT DISORDERS, 2023, 38 : S673 - S673
  • [39] The roles of resilience and nonmotor symptoms in adjustment to Parkinson's disease
    Shamaskin-Garroway, Andrea M.
    Lageman, Sarah K.
    Rybarczyk, Bruce
    JOURNAL OF HEALTH PSYCHOLOGY, 2016, 21 (12) : 3004 - 3015
  • [40] Biochemical pathways involved in higher resilience in Parkinson's disease
    Dzialas, V.
    Doering, E.
    Drzezga, A.
    Van Eimeren, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 702 - 702
12345